EDGAR Filing Documents for 0001213900-23-022155

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

SEC Accession No. 0001213900-23-022155

Filing Date

2023-03-23

Accepted

2023-03-22 18:18:17

Documents

168

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 5 TO FORM F-1	ea175596-f1a5_altamira.htm iXBRL	F-1/A	3742314
2	FORM OF UNDERWRITING AGREEMENT	ea175596ex1-1_altamira.htm	EX-1.1	397515
3	FORM OF WARRANT AGENT AGREEMENT FOR COMMON WARRANTS	ea175596ex4-19_altamira.htm	EX-4.19	270578
4	OPINION OF CONYERS DILL & PEARMAN LIMITED, BERMUDA COUNSEL TO THE COMPANY, AS TO	ea175596ex5-1_altamira.htm	EX-5.1	26483
5	OPINION OF LOWENSTEIN SANDLER LLP, U.S. COUNSEL TO THE COMPANY, AS TO THE VALIDI	ea175596ex5-2_altamira.htm	EX-5.2	14198
6	FORM OF AMENDMENT NO. 3 TO CONVERTIBLE LOAN AGREEMENT, BETWEEN ALTAMIRA THERAPEU	ea175596ex10-22_altamira.htm	EX-10.22	13879
7	CONSENT OF DELOITTE AG	ea175596ex23-1_altamira.htm	EX-23.1	4666
8	FILING FEE TABLE	ea175596ex-fee_altamira.htm	EX-FILING FEES	58257
9	GRAPHIC	image_001.jpg	GRAPHIC	3988
10	GRAPHIC	ex5-1_001.jpg	GRAPHIC	13771
	Complete submission text file	0001213900-23-022155.txt		16235367

Data Files

Seq	Description	Document	Type	Size
11	XBRL SCHEMA FILE	cyto-20220630.xsd	EX-101.SCH	240138
12	XBRL CALCULATION FILE	cyto-20220630_cal.xml	EX-101.CAL	43192
13	XBRL DEFINITION FILE	cyto-20220630_def.xml	EX-101.DEF	566991
14	XBRL LABEL FILE	cyto-20220630_lab.xml	EX-101.LAB	1160865
15	XBRL PRESENTATION FILE	cyto-20220630_pre.xml	EX-101.PRE	604096
162	EXTRACTED XBRL INSTANCE DOCUMENT	ea175596-f1a5_altamira_htm.xml	XML	2634189

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000

Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94

Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)